欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）
MR编号AT/H/0910/001
药品名称Nevirapine Mylan 400 mg Prolonged-Release Tablets
活性成分
    • nevirapine 400.0 mg
剂型Prolonged-release tablet
上市许可持有人Arcana Arzneimittel GmbH Hütteldorfer Straße 299 1140 Wien Austria Transfer von UK/H/5652/001
参考成员国 - 产品名称Austria (AT)
互认成员国 - 产品名称
    • Denmark (DK)
    • Finland (FI)
    • United Kingdom (Northern Ireland) (XI)
      Nevirapine Mylan 400 mg Prolonged-Release Tablets
    • Germany (DE)
      Nevirapin Mylan 400 mg Retardtabletten
    • Belgium (BE)
      Nevirapine Viatris 400 mg tabletten met verlengde afgifte
    • Netherlands (NL)
      Nevirapine Mylan 400 mg, tabletten met verlengde afgifte
    • Luxembourg (LU)
      Nevrapine Mylan, 400 mg, Comprimé à libération prolongée
    • France (FR)
    • Portugal (PT)
    • Italy (IT)
许可日期2016/06/14
最近更新日期2024/06/03
药物ATC编码
    • J05AG01 nevirapine
申请类型
  • TypeLevel1：[not specified]
  • TypeLevel2：[not specified]
  • TypeLevel3：[not specified]
  • TypeLevel4：[not specified]
  • TypeLevel5：[not specified]
附件文件下载
市场状态Positive
©2006-2024 Drugfuture->European Union HMA Authorisation of Medicines DataBase